Marie H Pahus

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 2

Top Topics

Top Venues

Nature medicine

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Jesper Damsgaard Gunst, Jesper Falkesgaard Højen, Marie H Pahus, Miriam Rosás-Umbert, Birgitte Stiksrud, James H McMahon, Paul W Denton, Henrik Nielsen, Isik Somuncu Johansen, Thomas Benfield, Steffen Leth, Jan Gerstoft, Lars Østergaard, Mariane Høgsbjerg Schleimann, Rikke Olesen, Henrik Støvring, Line K Vibholm, Nina Weis, Anne Margarita Dyrhol-Riise, Karen B H Pedersen, Jillian S Y Lau, Dennis C Copertino, Noemi Linden, Tan T Huynh, Victor Ramos, R Brad Jones, Sharon R Lewin, Martin Tolstrup, Thomas A Rasmussen, Michel C Nussenzweig, Marina Caskey, Dag Henrik Reikvam, Ole Schmeltz Søgaard
Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial. Nature medicine (2023)
Miriam Rosás-Umbert, Jesper Damsgaard Gunst, Marie H Pahus, Rikke Olesen, Mariane Høgsbjerg Schleimann, Paul W Denton, Victor Ramos, Adam R Ward, Natalie N Kinloch, Dennis C Copertino, Tuixent Escribà, Anuska Llano, Zabrina L Brumme, R Brad Jones, Beatriz Mothe, Christian Brander, Julie M Fox, Michel C Nussenzweig, Sarah Fidler, Marina Caskey, Martin Tolstrup, Ole Schmeltz Søgaard
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8 + T cell immunity. Nature communications 13 (1) (2022)